Skip to main content
Livermore
Livermore
ZHEN

RenovoRx, Inc.

RNXT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001574094

No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.

Holders of 5% or more of RNXT

Holders whose latest Schedule 13D or 13G filing reports 5% or more of RenovoRx, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of RNXT
HolderLatest formStakeChangeFirst filedLatest filingFiling
Hirschman Orin13G/A7.10%2.62M shares0.00 ppfrom 7.10%May 8, 20253 filingsJan 30, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

6 Schedule 13D and 13G filings on RenovoRx, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on RNXT
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jan 30, 202612:14 PM ETHirschman Orinand 1 other13G/A7.10%2.62M shares0.00 ppfrom 7.10%Dec 31, 2025SEC
Nov 13, 20252:53 PM ETAWM Investment Company, Inc.13G/A2.40%863.8K shares−2.70 ppfrom 5.10%Below 5%Sep 30, 2025SEC
Nov 10, 20258:45 AM ETHirschman Orinand 1 other13G/A7.10%2.62M shares−2.40 ppfrom 9.50%Sep 30, 2025SEC
Aug 14, 20254:42 PM ETAWM Investment Company, Inc.13G/A5.10%1.87M shares−1.20 ppfrom 6.30%Jun 30, 2025SEC
May 8, 20257:44 AM ETHirschman Orinand 1 other13G9.50%3.47M sharesNewMar 31, 2025SEC
May 7, 20254:34 PM ETAWM Investment Company, Inc.13G6.30%2.29M sharesNewMar 31, 2025SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell RenovoRx, Inc. shares.

No Form 144 notices for RenovoRx, Inc. are on file.